Johnson Health Tech .Co Future Growth

Future criteria checks 3/6

Johnson Health Tech .Co is forecast to grow earnings and revenue by 33.7% and 5.7% per annum respectively. EPS is expected to grow by 33.6% per annum. Return on equity is forecast to be 14.1% in 3 years.

Key information

33.7%

Earnings growth rate

33.6%

EPS growth rate

Leisure earnings growth	18.0%
Revenue growth rate	5.7%
Future return on equity	14.1%
Analyst coverage	Low
Last updated	26 Apr 2024

Recent future growth updates

Recent updates

Does Johnson Health Tech .Co (TWSE:1736) Have A Healthy Balance Sheet?

Apr 09

The Strong Earnings Posted By Johnson Health Tech .Co (TWSE:1736) Are A Good Indication Of The Strength Of The Business

Mar 23

Johnson Health Tech .Co (TWSE:1736) Shareholders Will Want The ROCE Trajectory To Continue

Mar 06

These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Extensively

Apr 26

Investors Met With Slowing Returns on Capital At Johnson Health Tech (TPE:1736)

Mar 27

Did You Miss Johnson Health Tech's (TPE:1736) Impressive 180% Share Price Gain?

Feb 25

Should Johnson Health Tech. Co., Ltd. (TPE:1736) Focus On Improving This Fundamental Metric?

Feb 10

These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Reasonably Well

Jan 26

Do Institutions Own Johnson Health Tech. Co., Ltd. (TPE:1736) Shares?

Jan 11

Returns On Capital At Johnson Health Tech (TPE:1736) Paint An Interesting Picture

Dec 27

The Johnson Health Tech (TPE:1736) Share Price Has Gained 144%, So Why Not Pay It Some Attention?

Nov 27

Earnings and Revenue Growth Forecasts

TWSE:1736 - Analysts future estimates and past financials data (TWD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	42,702	1,534	2,364	2,779	2
12/31/2024	40,375	1,417	1,090	3,881	1
12/31/2023	38,070	710	3,135	3,843	N/A
9/30/2023	36,838	590	1,989	2,404	N/A
6/30/2023	35,191	444	28	465	N/A
3/31/2023	33,122	-300	-632	-291	N/A
12/31/2022	33,613	429	-48	392	N/A
9/30/2022	31,863	369	-1,071	-238	N/A
6/30/2022	31,052	-361	-1,469	-651	N/A
3/31/2022	31,036	53	-3,659	-2,818	N/A
12/31/2021	30,779	38	-4,295	-3,537	N/A
9/30/2021	30,765	53	-3,341	-2,681	N/A
6/30/2021	31,024	1,011	-1,542	-798	N/A
3/31/2021	30,102	999	1,279	2,005	N/A
12/31/2020	28,367	679	2,107	2,942	N/A
9/30/2020	26,901	894	1,818	2,563	N/A
6/30/2020	25,584	784	1,680	2,409	N/A
3/31/2020	25,570	1,015	176	990	N/A
12/31/2019	25,373	1,293	234	943	N/A
9/30/2019	24,460	1,129	74	695	N/A
6/30/2019	23,708	979	-56	591	N/A
3/31/2019	22,609	612	743	1,337	N/A
12/31/2018	21,757	390	348	981	N/A
9/30/2018	20,769	189	131	956	N/A
6/30/2018	20,009	67	245	954	N/A
3/31/2018	19,540	-6	-924	13	N/A
12/31/2017	19,494	130	-1,019	-74	N/A
9/30/2017	19,477	358	N/A	-939	N/A
6/30/2017	19,958	453	N/A	-215	N/A
3/31/2017	20,191	716	N/A	818	N/A
12/31/2016	20,165	716	N/A	1,258	N/A
9/30/2016	19,659	710	N/A	2,014	N/A
6/30/2016	18,764	769	N/A	282	N/A
3/31/2016	17,963	563	N/A	-154	N/A
12/31/2015	16,975	564	N/A	-217	N/A
9/30/2015	16,520	1,940	N/A	-813	N/A
6/30/2015	16,345	1,976	N/A	703	N/A
3/31/2015	16,313	2,296	N/A	2,482	N/A
12/31/2014	16,551	2,638	N/A	1,851	N/A
9/30/2014	16,262	1,477	N/A	2,232	N/A
6/30/2014	15,939	1,366	N/A	1,642	N/A
3/31/2014	15,416	1,058	N/A	398	N/A
12/31/2013	15,071	857	N/A	773	N/A
9/30/2013	15,231	542	N/A	575	N/A
6/30/2013	15,261	672	N/A	585	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1736's forecast earnings growth (33.7% per year) is above the savings rate (1%).

Earnings vs Market: 1736's earnings (33.7% per year) are forecast to grow faster than the TW market (19.7% per year).

High Growth Earnings: 1736's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 1736's revenue (5.7% per year) is forecast to grow slower than the TW market (10.5% per year).

High Growth Revenue: 1736's revenue (5.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 1736's Return on Equity is forecast to be low in 3 years time (14.1%).

Johnson Health Tech .Co Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Price target decreased by 18% to NT$75.00

Consensus EPS estimates fall by 33%, revenue upgraded

Price target increased by 15% to NT$92.00

Price target decreased by 16% to NT$80.00

Consensus EPS estimates increase by 64%

Consensus EPS estimates increase by 25%

Recent updates

Does Johnson Health Tech .Co (TWSE:1736) Have A Healthy Balance Sheet?

The Strong Earnings Posted By Johnson Health Tech .Co (TWSE:1736) Are A Good Indication Of The Strength Of The Business

Full year 2023 earnings: EPS misses analyst expectations

Johnson Health Tech .Co., Ltd., Annual General Meeting, Jun 26, 2024

Johnson Health Tech .Co (TWSE:1736) Shareholders Will Want The ROCE Trajectory To Continue

Price target decreased by 18% to NT$75.00

Consensus EPS estimates fall by 33%, revenue upgraded

New minor risk - Earnings quality

Price target increased by 15% to NT$92.00

Second quarter 2023 earnings: EPS exceeds analyst expectations

Johnson Health Tech .Co., Ltd. Announces Principal Financial Officer Changes, Effective from August 14, 2023

Upcoming dividend of NT$0.60 per share at 0.8% yield

Johnson Health Tech .Co., Ltd. Announces Cash Dividend, Payable on August 25, 2023

Johnson Health Tech .Co., Ltd. Announces Cash Dividend, Payable on August 25, 2023

Johnson Health Tech .Co., Ltd. Approves Cash Dividend for the Year 2022

Price target decreased by 16% to NT$80.00

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Consensus EPS estimates increase by 64%

Consensus EPS estimates increase by 25%

Less than half of directors are independent

Third quarter 2022 earnings: EPS exceeds analyst expectations

Upcoming dividend of NT$0.50 per share

Johnson Health Tech .Co., Ltd. Announces Dividend, Payable on October 07, 2022

Johnson Health Tech .Co., Ltd. Approves Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Less than half of directors are independent

Johnson Health Tech .Co., Ltd., Annual General Meeting, Jun 27, 2022

Consensus EPS estimates fall by 53%

Third quarter 2021 earnings released: NT$1.67 loss per share (vs NT$1.49 profit in 3Q 2020)

Price target decreased to NT$96.25

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$1.12 per share

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS NT$0.01 (vs NT$0.029 loss in 2Q 2020)

Consensus EPS estimates fall to NT$3.88

First quarter 2021 earnings released: EPS NT$0.22 (vs NT$0.83 loss in 1Q 2020)

These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Extensively

Investors Met With Slowing Returns on Capital At Johnson Health Tech (TPE:1736)

Full year 2020 earnings released: EPS NT$2.24 (vs NT$4.26 in FY 2019)

Did You Miss Johnson Health Tech's (TPE:1736) Impressive 180% Share Price Gain?

Should Johnson Health Tech. Co., Ltd. (TPE:1736) Focus On Improving This Fundamental Metric?

These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Reasonably Well

Do Institutions Own Johnson Health Tech. Co., Ltd. (TPE:1736) Shares?

New 90-day high: NT$101

Returns On Capital At Johnson Health Tech (TPE:1736) Paint An Interesting Picture

New 90-day high: NT$85.50

The Johnson Health Tech (TPE:1736) Share Price Has Gained 144%, So Why Not Pay It Some Attention?

Analysts increase EPS estimates to NT$2.95

Revenue and earnings beat expectations

New 90-day high: NT$79.70

Third quarter 2020 earnings released: EPS NT$1.49

New 90-day high - NT$76.90

First half earnings released

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies